South Africa expands HIV prevention jab access to at-risk groups
South Africa expands HIV prevention jab access to at-risk groups, offering long-acting lenacapir protection for up to six months.
South Africa expands HIV prevention jab access to at-risk groups, offering long-acting lenacapir protection for up to six months.
Deon Ramgoolam finds confidence with obesity medication, overcoming lifelong struggles with weight.
South Africa expands HIV prevention jab access to at-risk groups, offering long-acting lenacapir protection for up to six…
Cancer patients may face logistical challenges during treatment, about one of life's toughest experiences.
Child myopia affects up to one‑third of Canadian kids, but experts say daily outdoor time can slow its…
Ovarian cancer patient Gertrude Spatafora shares how faith and family support helped her navigate treatment after a shocking…